Stock Split History
Intellia Therapeutics stock split history picture
Intellia Therapeutics (NTLA) has 0 splits in our Intellia Therapeutics stock split history database.

Looking at the Intellia Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Intellia Therapeutics shares, starting with a $10,000 purchase of NTLA, presented on a split-history-adjusted basis factoring in the complete Intellia Therapeutics stock split history. Intellia Therapeutics split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/09/2016
End date: 04/29/2024
Start price/share: $24.00
End price/share: $21.98
Dividends collected/share: $0.00
Total return: -8.42%
Average Annual Total Return: -1.10%
Starting investment: $10,000.00
Ending investment: $9,155.36
Years: 7.98
Intellia Therapeutics is a genome editing company focused on developing therapeutics using CRISPR/Cas9 technology. CRISPR/Cas9, an acronym for Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated 9 (Cas9), is a technology for genome editing, the process of altering selected sequences of genomic deoxyribonucleic acid (DNA). To realize the transformative potential of CRISPR/Cas9-based technologies, Co. is building a range of genome editing company, by utilizing its modular platform, to advance in vivo and ex vivo therapies for diseases with high unmet need. According to our Intellia Therapeutics stock split history records, Intellia Therapeutics has had 0 splits.
Date Ratio
Gaucho Group Holdings, Inc. (VINO)
STRATA Skin Sciences, Inc. (SSKN)
Society Pass Inc. (SOPA)
Recon Technology, Ltd. (RCON)
iSun, Inc. (ISUN)
Avenue Therapeutics, Inc. (ATXI)
Bakkt Holdings, Inc. (BKKT)
Applied DNA Sciences, Inc. (APDN)
Cidara Therapeutics, Inc. (CDTX)
Smart for Life, Inc. (SMFL)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Intellia Therapeutics
Intellia Therapeutics Insider Buying

Intellia Therapeutics Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.